Abstract:Objective To explore the application value of optical coherence tomography (OCT) in layered coronary plaque lesions in acute myocardial infarction (AMI).MethodsFrom January 2019 to October 2022, 60 patients diagnosed with AMI due to plaque erosion after undergoing coronary angiography (CAG) and OCT on target vessels at the Cardiovascular Department of Jilin Central Hospital were collected. Based on OCT image findings, the patients were categorized into a layered plaque erosion group (28 cases) and a non-layered plaque erosion group (32 cases). The 2 groups of patients′ demographic data, previous disease history, cardiovascular medication history, clinical biochemical data, CAG data and OCT data were all compared.ResultsIn 60 cases of AMI patients, 28 cases had layered plaque erosion, accounting for 46.67%. In the layered plaque erosion group, the levels of low-density lipoprotein [(3.38±0.27)mmol/L] and glycosylated hemoglobin [(7.38±0.24)%]were significantly higher than those in non-layered plaque erosion patients [(2.42±0.15)mmol/L, (6.00±0.58)%], and the differences were statistically significant (t=6.00, 3.23, all P<0.05). CAG showed that compared to non-layered plaque erosion group, the erosion of layered plaques were more commonly seen in the left anterior descending branch of the coronary artery [18/28(64.29%),12/32(37.50%)], with longer lesion lengths [(28.64±4.38)mm, (15.23±4.32)mm], and more complex lesions (B2/C type) [16/28(57.14%),8/32(25.00%)], and the differences were statistically significant (χ2=4.29, t=11.92, χ2=6.43, all P<0.05). Regarding OCT characteristics of target vessels, comparing to non-layered plaque erosion group, the fibrous cap was thinner [(91.78±7.89)μm, (120.89±7.18)μm], the lipid plaque radian was larger [(270.21±59.89)°, (206.58±58.61)°], the minimum lumen area (MLA) was smaller [(1.25±0.21)mm2, (1.77±0.24)mm2], and the degree of vascular stenosis was more severe [(88.38±9.56)%, (76.45±8.38)%] in layered plaque erosion group (t=14.96, 2.48, 8.87, 2.56, all P<0.05). Compared to those in non-layered plaque erosion group, the macrophages [19/28(67.86%), 12/32(37.50%)], nourishing vessels [8/28(28.57%), 2/32(6.25%)], cholesterol crystallization [15/28(53.57%), 8/32(25.00%)], clot burden [25/28(89.29%), 21/32(65.63%)], and thin-cap fibroatheroma [20/28(71.43%), 14/32(43.75%)] were found more frequently in layered plaque erosion group (χ2=5.51, 3.87, 5.16, 4.67, 4.66, all P<0.05). The stent length [(30.00±5.64)mm, (18.00±7.42)mm], stent expansion ratio [14/28(50.00%), 8/32(25.00%)], stent malapposition [12/28(42.86%), 6/32(18.75%)] were significantly different between the layered plaque erosion and non-layered plaque erosion in AMI patients (t=9.32, χ2=4.02, 3.87, all P<0.05). Compared to non-layered plaque erosion group, AMI patients with layered plaque erosion might have more aggressive post-dilatations [22/28(78.57%), 10/32(31.25%)], and have higher post stent expansion pressure [(18.00±2.68)atm, (14.00±2.46)atm] (1atm=101.3kPa) (χ2=4.25, t=2.47, all P<0.05). In the 2 groups, the accumulated major adverse cardiovascular events (MACE) at 12 months postoperatively were related to target vessel revascularization, with 1 case and 2 cases, respectively. The target vessel revascularization rate in the layered plaque erosion group(2/28, 7.14%) was higher than that in the non-layered plaque erosion group (1/32, 3.13%), but the difference was not statistically significant (P=0.594). ConclusionThe erosion of layered plaques is closely related to the characteristics of lesions and clinical manifestations of patients. OCT has potential application prospects in evaluating the therapeutic effects of PCI in AMI patients with eroded layered plaques, providing personalized treatment guidance.
[1]Mann J,Davies MJ.Mechanisms of progression in native coronary artery disease:role of healed plaque disruption[J].Heart,1999,82(3):265-268.DOI:10.1136/hrt.82.3.265.
[2]Yuki H,Kinoshita D,Suzuki K,et al.Layered plaque and plaque volume in patients with acute coronary syndromes[J].J Thromb Thrombolysis,2023,55(3):432-438.DOI:10.1007/s11239-023-02788-9.
[3]Shimokado A,Matsuo Y,Kubo T,et al.In vivo optical coherence tomography imaging and histopathology of healed coronary plaques[J].Atherosclerosis,2018(275):35-42.DOI:10.1016/j.atherosclerosis.2018.05.025.
[4]Dai J,Fang C,Zhang S,et al.Frequency,predictors,distribution,and morphological characteristics of layered culprit and nonculprit plaques of patients with acute myocardial infarction:in vivo 3-vessel optical coherence tomography study[J].Circ Cardiovasc Interv,2020,13(10):e009125.DOI:10.1161/CIRCINTERVENTIONS.120.009125.
[5]Kimura S,Cho S,Misu Y,et al.Optical coherence tomography and coronary angioscopy assessment of healed coronary plaque components[J].Int J Cardiovasc Imaging,2021,37(10):2849-2859.DOI:10.1007/s10554-021-02287-z.
[6]Russo M,Kim HO,Kurihara O,et al.Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque[J].Eur Heart J Cardiovasc Imaging,2020,21(12):1421-1430.DOI:10.1093/ehjci/jez308.
[7]Kurihara O,Shinohara H,Kim HO,et al.Comparison of post-stent optical coherence tomography findings:layered versus non-layered culprit lesions[J].Catheter Cardiovasc Interv,2021,97(7):1320-1328.DOI:10.1002/ccd.28940.
[8]Kurihara O,Russo M,Kim HO,et al.Clinical significance of healed plaque detected by optical coherence tomography:a 2-year follow-up study[J].J Thromb Thrombolysis,2020,50(4):895-902.DOI:10.1007/s11239-020-02076-w.
[9]Gulati M,Levy PD,Mukherjee D,et al.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J].Circulation,2021,144(22):e368-e454.DOI:10.1161/CIR.0000000000001029.
[10]Bhatt DL,Lopes RD,Harrington RA.Diagnosis and treatment of acute coronary syndromes:a review[J].JAMA,2022,327(7):662-675.DOI:10.1001/jama.2022.0358.
[11]Okamoto H,Kume T, Yamada R, et al. Prevalence and clinical significance of layered plaque in patients with stable angina pectoris-evaluation with histopathology and optical coherence tomography[J].Circ J,2019,83(12):2452-2459.DOI:10.1253/circj.CJ-19-0640.
[12]Jia H,Abtahian F,Aguirre AD,et al.In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography[J].J Am Coll Cardiol,2013,62(19):1748-1758.DOI:10.1016/j.jacc.2013.05.071.
[13 ]Prati F,Regar E,Mintz GS,et al.Expert review document on methodology,terminology,and clinical applications of optical coherence tomography:physical principles,methodology of image acquisition,and clinical application for assessment of coronary arteries and atherosclerosis[J].Eur Heart J,2010,31(4):401-415.DOI:10.1093/eurheartj/ehp433.
[14]Tearney GJ,Regar E,Akasaka T,et al.Consensus standards for acquisition,measurement,and reporting of intravascular optical coherence tomography studies:a report from the International working group for intravascular optical coherence tomography standardization and validation[J].J Am Coll Cardiol,2012,59(12):1058-1072.DOI:10.1016/j.jacc.2011.09.079.
[15]Min HS,Yoo JH,Kang SJ,et al.Detection of optical coherence tomography-defined thin-cap fibroatheroma in the coronary artery using deep learning[J].EuroIntervention,2020,16(5):404-412.DOI:10.4244/EIJ-D-19-00487.
[16]Meneveau N,Souteyrand G,Motreff P,et al.Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome:results of the multicenter,randomized DOCTORS study (Does Optical Coherence Tomography Optimize Results of Stenting)[J].Circulation,2016,134(13):906-917.DOI:10.1161/CIRCULATIONAHA.116.024393.
[17]Prati F,Guagliumi G,Mintz GS,et al.Expert review document part 2:methodology,terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures[J].Eur Heart J,2012,33(20):2513-2520.DOI:10.1093/eurheartj/ehs095.
[18]Leone AM,Rebuzzi AG,Burzotta F,et al.Stent malapposition,strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction[J].J Cardiovasc Med (Hagerstown),2019,20(3):122-130.DOI:10.2459/JCM.0000000000000749.
[19]Fracassi F,Crea F,Sugiyama T,et al.Healed culprit plaques in patients with acute coronary syndromes[J].J Am Coll Cardiol,2019,73(18):2253-2263.DOI:10.1016/j.jacc.2018.10.093.
[20]Cosansu K,Ureyen CM,Vatan MB,et al.Impact of direct stenting on clinical outcomes for small vessel coronary artery disease in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction[J].Postepy Kardiol Interwencyjnej,2019,15(4):404-411.DOI:10.5114/aic.2019.90214.
[21]Wang C,Hu S,Wu J,et al.Characteristics and significance of healed plaques in patients with acute coronary syndrome and stable angina:an in vivo OCT and IVUS study[J].EuroIntervention,2019,15(9):e771-e778.DOI:10.4244/EIJ-D-18-01175.
[22]Virmani R,Kolodgie FD,Burke AP,et al.Lessons from sudden coronary death:a comprehensive morphological classification scheme for atherosclerotic lesions[J].Arterioscler Thromb Vasc Biol,2000,20(5):1262-1275.DOI:10.1161/01.atv.20.5.1262.
[23]Kobielarz M,Kozuń M,Gsior-Gogowska M,et al.Mechanical and structural properties of different types of human aortic atherosclerotic plaques[J].J Mech Behav Biomed Mater,2020(109):103837.DOI:10.1016/j.jmbbm.2020.103837.
[24]Foin N,Lu S,Ng J,et al.Stent malapposition and the risk of stent thrombosis:mechanistic insights from an in vitro model[J].EuroIntervention,2017,13(9):e1096-e1098.DOI:10.4244/EIJ-D-17-00381.
[25]Yin Y,Fang C,Jiang S,et al.In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging[J].Am Heart J,2022(243):66-76.DOI:10.1016/j.ahj.2021.09.007.